Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.53 - $0.93 $9.61 Million - $16.9 Million
18,128,512 Added 151.26%
30,113,712 $17.5 Million
Q4 2023

Feb 14, 2024

SELL
$0.63 - $1.14 $3.55 Million - $6.42 Million
-5,630,611 Reduced 31.96%
11,985,200 $9.95 Million
Q3 2023

Nov 14, 2023

SELL
$1.12 - $1.88 $1,312 - $2,203
-1,172 Reduced 0.01%
17,615,811 $19.9 Million
Q2 2023

Aug 14, 2023

BUY
$1.31 - $2.04 $12.8 Million - $19.9 Million
9,776,083 Added 124.68%
17,616,983 $28.2 Million
Q1 2023

May 15, 2023

SELL
$1.45 - $2.95 $1.57 Million - $3.19 Million
-1,082,400 Reduced 12.13%
7,840,900 $11.9 Million
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $1.11 Million - $1.79 Million
551,100 Added 6.58%
8,923,300 $21.4 Million
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $14.8 Million - $23.8 Million
7,569,600 Added 943.13%
8,372,200 $17.2 Million
Q2 2022

Aug 15, 2022

BUY
$1.3 - $2.64 $1.04 Million - $2.12 Million
802,600 New
802,600 $1.56 Million
Q3 2021

Nov 15, 2021

SELL
$4.98 - $6.63 $10.2 Million - $13.6 Million
-2,045,800 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$2.56 - $5.49 $1.51 Million - $3.23 Million
-588,000 Reduced 22.33%
2,045,800 $11.2 Million
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $7.08 Million - $13.8 Million
2,633,800 New
2,633,800 $7.16 Million
Q2 2018

Aug 14, 2018

SELL
$2.26 - $4.65 $7.84 Million - $16.1 Million
-3,469,613 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$3.51 - $6.04 $12.2 Million - $21 Million
3,469,613 New
3,469,613 $16.3 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.